SE447871B - Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar - Google Patents

Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar

Info

Publication number
SE447871B
SE447871B SE8400723A SE8400723A SE447871B SE 447871 B SE447871 B SE 447871B SE 8400723 A SE8400723 A SE 8400723A SE 8400723 A SE8400723 A SE 8400723A SE 447871 B SE447871 B SE 447871B
Authority
SE
Sweden
Prior art keywords
pellets
pinacidil
pharmaceutical composition
eudragit
content
Prior art date
Application number
SE8400723A
Other languages
English (en)
Swedish (sv)
Other versions
SE8400723L (sv
SE8400723D0 (sv
Inventor
E J Didriksen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of SE8400723D0 publication Critical patent/SE8400723D0/xx
Publication of SE8400723L publication Critical patent/SE8400723L/
Publication of SE447871B publication Critical patent/SE447871B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE8400723A 1983-02-11 1984-02-10 Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar SE447871B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK0589/83A DK58983D0 (da) 1983-02-11 1983-02-11 Farmaceutisk praeparat

Publications (3)

Publication Number Publication Date
SE8400723D0 SE8400723D0 (sv) 1984-02-10
SE8400723L SE8400723L (sv) 1984-08-12
SE447871B true SE447871B (sv) 1986-12-22

Family

ID=8095276

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8400723A SE447871B (sv) 1983-02-11 1984-02-10 Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar

Country Status (15)

Country Link
US (1) US4600577A (nl)
JP (1) JPS59155312A (nl)
BE (1) BE898882A (nl)
DE (1) DE3404595A1 (nl)
DK (1) DK58983D0 (nl)
ES (1) ES8608490A1 (nl)
FR (1) FR2540727B1 (nl)
GB (1) GB2134785B (nl)
IE (1) IE56604B1 (nl)
IT (1) IT1196682B (nl)
NL (1) NL8400430A (nl)
NZ (1) NZ207010A (nl)
PH (1) PH21734A (nl)
SE (1) SE447871B (nl)
ZA (1) ZA84856B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
EP0302595B1 (en) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil for treatment of pulmonary hypertension or right heart failure
US5009894A (en) * 1988-03-07 1991-04-23 Baker Cummins Pharmaceuticals, Inc. Arrangement for and method of administering a pharmaceutical preparation
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
WO2000044353A1 (de) 1999-01-29 2000-08-03 Losan Pharma Gmbh Pharmazeutische zusammensetzungen
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
CA2403670C (en) * 2001-01-31 2010-02-09 Rohm Gmbh & Co. Kg Multiparticulate drug form comprising at least two differently coated pellet forms
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
JP5629581B2 (ja) 2007-10-12 2014-11-19 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド 食物の摂取から独立した消化器疾患の治療方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe

Also Published As

Publication number Publication date
DK58983D0 (da) 1983-02-11
ZA84856B (en) 1984-09-26
US4600577A (en) 1986-07-15
IE840146L (en) 1984-08-11
NZ207010A (en) 1987-06-30
NL8400430A (nl) 1984-09-03
IT1196682B (it) 1988-11-25
PH21734A (en) 1988-02-10
BE898882A (fr) 1984-08-10
GB2134785B (en) 1986-07-02
DE3404595C2 (nl) 1993-04-29
GB8403572D0 (en) 1984-03-14
JPH0451528B2 (nl) 1992-08-19
FR2540727B1 (fr) 1987-01-23
FR2540727A1 (fr) 1984-08-17
IE56604B1 (en) 1991-10-09
SE8400723L (sv) 1984-08-12
DE3404595A1 (de) 1984-08-16
IT8467131A0 (it) 1984-02-13
SE8400723D0 (sv) 1984-02-10
GB2134785A (en) 1984-08-22
JPS59155312A (ja) 1984-09-04
ES529660A0 (es) 1986-06-16
ES8608490A1 (es) 1986-06-16

Similar Documents

Publication Publication Date Title
EP0069097B1 (en) Pharmaceutical mixture
US4772475A (en) Controlled-release multiple units pharmaceutical formulation
AU680891C (en) Controlled release preparation containing a salt of morphine
EP0425659B1 (en) SUSTAINED RELEASE PHARMACEUTICAL PREPARATIONS HAVING pH CONTROLLED MEMBRANE COATINGS
US5149542A (en) Coating membrane and compositions prepared therefrom
FI78835C (fi) Foerfarande foer framstaellning av en ny dipyridamol-retardform.
JP2560019B2 (ja) 活性化合物の放出を制御する新規な製剤およびその製造法
EP0519870B1 (de) Neue orale Diclofenaczubereitung
SE447871B (sv) Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar
DE3024858A1 (de) Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials
BG65398B1 (bg) Ентерично покрит фармацевтичен състав и метод за получаване
SE457505B (sv) Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE2336218A1 (de) Neue orale arzneiform und verfahren zu ihrer herstellung
HUT75683A (en) Delayed, sustained-release pharmaceutica preparations
SE455836B (sv) Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SK9899A3 (en) Tramadol multiple unit formulations
AU2003269067A1 (en) Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with low solubility
CA2000932C (en) Oral pharmaceutical controlled release multiple unit dosage form
JPS58116414A (ja) ニカルジピン持続性製剤用球形顆粒およびその製造法
US20020076444A1 (en) Novel method for obtaining microspheres and resulting products
KR20020015721A (ko) 키토산 분말 함유 고형 제제 및 그의 제조방법
JP2005537270A (ja) 強化味覚マスキング能および高溶出速度を有するマイクロカプセル製剤の製造方法
JP2002284694A (ja) 一日一回投与に適した経口投与用リチウム塩の多粒子製剤
US5888545A (en) Carbamazepine medicament with retarded active substance release
SE460946B (sv) En multipel-unit-dos komposition av kinidinglukonat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8400723-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8400723-6

Format of ref document f/p: F